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Abstract 31 
The phosphorylation status of red blood cell proteins is strongly altered during the 32 
infection by the malaria parasite Plasmodium falciparum. We identify the key 33 
phosphorylation events that occur in the erythrocyte membrane and cytoskeleton 34 
during infection, by a comparative analysis of global phospho-proteome screens 35 
between infected (obtained at schizont stage) and uninfected RBCs. The meta-36 
analysis of reported mass spectrometry studies revealed a novel compendium of 495 37 
phosphorylation sites in 182 human proteins with regulatory roles in red cell 38 
morphology and stability, with about 25% of these sites specific to infected cells. A 39 
phosphorylation motif analysis detected 7 unique motifs that were largely mapped to 40 
kinase consensus sequences of casein kinase II and of protein kinase A / protein 41 
kinase C. This analysis highlighted prominent roles for PKA / PKC involving 78 42 
phosphorylation sites. We then compared the phosphorylation status of PKA (PKC) 43 
specific sites in adducin, dematin, Band 3 and GLUT-1 in uninfected RBC stimulated 44 
or not by cAMP to their phosphorylation status in iRBC. We showed cAMP-induced 45 
phosphorylation of adducin S59 by immunoblotting and we were able to demonstrate 46 
parasite-induced phosphorylation for adducin S726, Band 3 and GLUT-1, 47 
corroborating the protein phosphorylation status in our erythrocyte phosphorylation 48 
site compendium. 49 
 50 
 51 
Abbreviations:  52 
CK1 and CK2, casein kinases I and II; GO, gene ontology; GLUT-1, glucose 53 
transporter 1; iRBC, infected red blood cell; LC-MS/MS, liquid chromatography 54 
tandem mass spectrometry; LFQ, label free quantification; PTMs, post-translational 55 
modifications; PKA, protein kinase A; PKC, protein kinase C 56 
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1.1 Introduction 61 
Mammalian erythrocytes have been widely studied for cytoskeleton structure, 62 
membrane composition and transport properties. Over the last decade, numerous 63 
studies have incorporated mass spectrometry techniques to mine and quantify the 64 
proteins expressed in red blood cells (RBCs) and to link these proteins functionally to 65 
various physiological or pathophysiological situations. However, even if these cells 66 
have a simple structural organization and specific function, proteomics studies have 67 
proven difficult to get a good overview of the diversity of proteins in RBCs for several 68 
reasons: (i) the abundance of ultra-majoritarian proteins in the cytosol (haemoglobin, 69 
up to 98% of cytosolic proteins at an unrivalled concentration: 5 mM – 340 g/l) and in 70 
the membrane (Band 3, 1 M copies/cell) and (ii) the tight links between membrane 71 
and sub-membranous cytoskeleton. With the progression of techniques, the number 72 
of proteins identified has raised to an unexpected number of 1578 unique proteins in 73 
the cytosol [1], and a total number of 2289 unique proteins in the RBC identified so 74 
far [2]. 75 
The next challenge now is to link these proteins to physiological processes, and one 76 
key feature is to elucidate the regulatory role of various post-translational 77 
modifications (PTMs). These modifications include oxidation effects, glycosylation, 78 
palmitoylation and most of all protein phosphorylation. Indeed, kinase activities have 79 
been described as a key regulatory mechanism in RBC and deregulation of their 80 
activities seems to be implicated in multiple diseases [3] including malaria, the focus 81 
of this study. Human RBCs in circulation harbour various active protein kinases, 82 
including protein kinase C (PKC), protein kinase A (PKA), casein kinases I and II 83 
(CK1 and CK2), Syk, Lyn, Hck-Fgr, and Fyn, as reviewed by Pantaleo et al. [4]. 84 
Activity of these kinases has been mostly studied regarding their effects on 85 
cytoskeleton or membrane proteins in various physiological or pathophysiological 86 
contexts. 87 
Spectrin phosphorylation by casein kinase has been associated with membrane 88 
destabilization [5] and enhanced spectrin phosphorylation is linked to hereditary 89 
elliptocytosis and pyropoikilocytosis [6]. The horizontal junctional complex 90 
components are also phosphorylated; the combined phosphorylation of adducin and 91 
protein 4.1 by PKC decreased their binding to spectrin and actin, resulting in weaker 92 
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membrane stability [7]; dematin is known to be phosphorylated by PKA, leading to 93 
disruption of actin/spectrin binding [8]. Regarding vertical complexes and integral 94 
membrane proteins, Band 3 PTMs have been widely studied (in regard to its pivotal 95 
role in membrane transport and structure). Notably, Band 3 tyrosine phosphorylation 96 
triggers its dissociation from ankyrin, consequently releasing Band 3 from 97 
spectrin/actin cytoskeleton [9]. 98 
The present study focusses on the changes in RBC protein phosphorylation resulting 99 
from infection with the human malaria causing parasite Plasmodium falciparum. 100 
During its complex life cycle, the parasite invades RBCs, where it is largely hidden 101 
from the host immune system. Inside erythrocytes it multiplies via the process of 102 
schizogony every 48 h to form up to 32 new merozoites. After rupture of infected 103 
RBCs, merozoites are released to invade fresh red cells and to complete a new 104 
cycle of asexual development. During intra-erythrocytic development, the parasite 105 
remodels the red blood cell surface, notably by exporting proteins to the host cytosol 106 
and membrane and by forming knobs that mediate interactions with host endothelial 107 
cells to escape clearance of infected RBCs (iRBC) by the spleen. The process of 108 
sequestration and cytoadherence of iRBCs results in clogging of blood vessels in 109 
various organs and it contributes to the clinical symptoms of malaria. Host cell 110 
permeability [10] or deformability [11] are also largely modified upon infection. 111 
Various exported parasite proteins play crucial roles in this process, and lately it’'s 112 
becoming clear that an involvement of host proteins is also required for parasite-113 
mediated host cell remodelling. Multiple host proteins see their phosphorylation 114 
status altered during infection, which was demonstrated by the pioneering study of 115 
Wu et al. [12], who in 2009 showed increased phosphorylation during parasite 116 
infection by immunoblotting and mass spectrometry. With the emergence of liquid 117 
chromatography tandem mass spectrometry, several studies [13––16] followed with 118 
phospho-proteome analyses of iRBCs, but remarkably largely ignored published 119 
data on phosphorylation sites identified in human red blood cell proteins. This study 120 
summarizes our current knowledge on RBC phosphorylation by comparing published 121 
phosphorylation sites measured in normal and P. falciparum infected RBCs and 122 
experimentally validating some of the major findings. 123 
 124 
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2. Material and methods 125 
2.1. Compendium of red blood cell phosphorylation sites 126 
Phospho-peptide sequences identified in large scale RBC phospho-proteome LC–127 
MS/MS studies with data taken from normal [17] and P. falciparum-infected RBCs at 128 
the schizont life cycle stage [13–16] were remapped to the UNIPROT protein 129 
database using the software tool Protein Coverage Summarizer 130 
(http://omics.pnl.gov/software/protein-coverage-summarizer) in order to generate a 131 
uniform format for comparing phosphorylation sites across data sets. The 132 
compendium of phospho-sites included all sites detected in normal RBCs from 133 
Soderblom et al. [17], and sites from infected RBCs that were detected at least twice 134 
in the four independent studies [13–16]. 135 
2.2. Phosphorylation motif analyses 136 
Phosphorylation sites were categorized by their chemical properties as acidic, basic, 137 
proline-directed, tyrosine or other by a decision tree method described previously [14] 138 
as follows: 1) get the 6 neighbouring amino acids before and after the 139 
phosphorylation site; 2) pY at position 0 then classify as “Tyrosine”; 3) P at+1 then 140 
classify as “Proline-directed”; 4) positions +1 to +6 contain more than one D and E 141 
residues then classify as “Acidic”; 5) K or R at position −3 then classify as “Basic”; 6) 142 
D or E at +1,+2, or +3 then classify as “Acidic”; 7) between −6 and −1 more than 2 K 143 
or R residues then classify as “Basic”; 8) remaining peptides classify as “Other”. 144 
Phosphorylation motifs were identified using MotifX [18] with the following 145 
parameters: phosphorylation motif window = 13 amino acids, p-value threshold = 1 ∗ 146 
10−4 for S and T residues, 1 ∗ 10−3 for Y residues, motif fold increase ≥2, a motif 147 
frequency N5, and a background of all RBC proteins identified. The analysis was 148 
repeated for a degenerate amino acid set with conservative amino acid substitutions 149 
within the motif window according to: A = AG, D = DE, F = FY, K = KR, I = ILVM, Q = 150 
QN, S = ST, C = C,H=H, P=P,W=W. When different motifs were found for a peptide 151 
by the analyses with different amino acid residues, priority was given to the motif 152 
with the highest MotifX score. Sequence logos were generated with Weblogo 3 [19] 153 
from http://weblogo.threeplusone.com/create.cgi. The motifs were matched to known 154 
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protein kinase target motifs using PhosphoMotifFinder [20] and matches were 155 
considered as potential links between phosphorylation motifs and protein kinases. 156 
2.3. Gene ontology (GO) analysis 157 
GO enrichment analyses of lists of membrane-associated phosphoproteins from 158 
infected and normal RBCs were carried out using the web tool Database for 159 
Annotation Visualization and Integrated Discovery (DAVID, version 6.7. 160 
http://david.abcc.ncifcrf.gov/) [21,22] with a background set of all human proteins. 161 
Enrichment of GO FAT terms was considered statistically significant when corrected 162 
for multiple testing by the Benjamini–Hochberg method with adjusted p-values lower 163 
than 0.05. Overlap between enriched GO terms was visualised in a network with the 164 
Cytoscape plugin Enrichment Map [23]. 165 
2.4. Cell preparation and Western blotting 166 
Human RBCs were drawn from healthy volunteers under informed consent, washed 167 
several times in RPMI, kept in culture medium (see below) and used within one week 168 
of collection. P. falciparum NF54 was grown in RBCs as described previously, using 169 
0.5% Albumax II® (Invitrogen) instead of human serum [52]. Parasites were 170 
synchronized twice using 5% w/v sorbitol solution according to Lambros and 171 
Vanderberg [53]. Schizont-stage parasite cultures were then enriched to N95% by 172 
centrifugation on a 70% Percoll/sorbitol solution as described in [24]. Parasite growth 173 
and development of schizont stages was monitored by Giemsa-stained thin blood 174 
smears. Uninfected RBC controls were incubated for 48 h in culture medium at 37 °C 175 
and kept in the presence or absence of 50 μM dibutyryl-cAMP (Sigma Aldrich), a 176 
cell-permeable non-hydrolysable cAMP analogue that activates protein kinase A, for 177 
the last 30 min before harvesting. Cell counts were determined by using a 178 
Cellometer Mini (Nexcelom Bioscience) automated cell counter following 179 
manufacturer's recommendations. 180 
Western blotting of uninfected RBCs and P. falciparum-infected RBC (1 × 107) 181 
samples was performed using erythrocyte ghosts. Briefly, RPMI-washed 182 
erythrocytes were incubated in 20 volumes of ice-cold hypotonic buffer 5P8 (5 mM 183 
NaH2PO4, pH 8.0) containing 1 mM phenylmethylsulfonyl fluoride, protease inhibitor 184 
mix (1 μg each of chymostatin, leupeptin, antipain, and pepstatin and 8 μg aprotinin 185 
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per ml), and phosphatase inhibitors (10 mM Na fluoride, 2mMβ-D glycerophosphate, 186 
1 mM Na orthovanadate), then washed several times in 5P8 containing protease and 187 
phosphatase inhibitors (30 min centrifugation 14,000 ×g at 4 °C). Membrane proteins 188 
were solubilized in lysis buffer (150 mM NaCl, 10 mM KCl, 1 mM MgCl2, 20mM Tris–189 
HCl pH 7.5, 1% Triton X-100) in the presence of protease and phosphatase 190 
inhibitors. P. falciparum-infected RBC samples were further lysed by sonication 191 
followed by centrifugation at 10,000 ×g. Dephosphorylation of proteins was achieved 192 
by incubation with λ-protein phosphatase in 1× NE Buffer (New England BioLabs, 193 
Inc.) supplemented with 1 mM MnCl2 for 30 min at 30 °C. A Bradford protein assay 194 
kit (Bio-Rad Laboratories) was used to determine protein concentrations. Protein 195 
samples diluted in reducing Laemmli buffer were separated using NuPAGE 10% Bis-196 
Tris (Invitrogen) SDS-PAGE. Western blotting was performed using standard 197 
methods. Antibodies used to probe RBC membrane antigens were rabbit monoclonal 198 
anti-α-adducin phospho Ser59 (Abcam ab76251) 1/500; rabbit polyclonal anti-α-199 
adducin phospho Ser726 (Santa Cruz sc101627) 1/200; mouse monoclonal anti-α-200 
adducin (Abcam ab54985) 1/1000; rabbit polyclonal anti-dematin phospho Ser 403 201 
(Sigma-Aldrich SAB4504167), 1/500; mouse polyclonal anti-dematin (Abcam 202 
ab89161) 1/500; horseradish peroxidase-conjugated goat anti-rabbit IgG (H + L)/goat 203 
anti-mouse IgG (H + L) (Bio-Rad Laboratories) 1/3000. Pierce ECL 2 Western 204 
blotting detection reagent (Thermo Scientific) was used and fluorescent signals were 205 
captured by Typhoon fluorescence imager (GE Healthcare Life Sciences). 206 
For immunoprecipitation, uninfected RBCs and P. falciparum infected RBC (1 × 108) 207 
lysates were incubated with rabbit monoclonal anti-phospho-Akt substrate RxxS*/T* 208 
(110B7E) antibody conjugated to sepharose beads (9646 Cell Signalling) for 4 h at 209 
4 °C, then washed 3 times with lysis buffer containing protease and phosphatase 210 
inhibitors. Samples were eluted by boiling the beads in reducing Laemmli buffer, 211 
then subjected to SDS-PAGE and Western blotting using standard methods. 212 
Membranes were probed with mouse monoclonal anti-Band 3 (BIII-136, Sigma 213 
B9277) 1/20,000 and mouse monoclonal anti-GLUT-1 (Abcam ab40084) 1/2500. 214 
  215 
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2.5. Mass spectrometry 216 
Ghost preparations of uninfected RBCs and Percoll-purified schizont stage P. 217 
falciparum-infected RBCs (N95% enrichment, 100 μg) were digested in solution by 218 
trypsin using the FASP procedure [25], and tryptic peptides were purified by STAGE 219 
tips [26]. Liquid chromatography tandem mass spectrometry analysis of tryptic 220 
peptides (500 ng) was performed on the Orbitrap Velos Pro mass spectrometer 221 
(Thermo Fisher, Bremen, Germany) equipped with the Ultimate 3000 UPLC system 222 
(Thermo Fisher, Germany) as previously described in [27]. Protein identification at 1% 223 
FDR and label free quantification (LFQ) were performed using MaxQuant [28] with 224 
settings that were described in [27]. 225 
3. Results 226 
3.1. Compendium of protein phosphorylation sites in red blood cells 227 
Changes in phosphorylation events at serine, threonine and tyrosine amino acid 228 
residues of human red cell proteins induced by infection with the malaria parasite P. 229 
falciparum were established by a comparative analysis of the four published 230 
phospho-proteomes of parasite-infected cells [13–16] with normal red cells [17]. 231 
Large scale P. falciparum phospho-proteome studies were primarily focussed at the 232 
schizont intra-cellular life cycle stage identifying more than 9000 parasite 233 
phosphorylation sites at various confidence levels [29]. We therefore required 234 
detection by at least two independent studies for inclusion of human red blood cell 235 
phosphorylation sites in this study. The uninfected red cell phosphorylation sites 236 
were taken from the work of Soderblom et al. as part of their investigation of the 237 
ERK1/2-mediated human phosphorylation changes in sickle red blood cell 238 
membrane [17]. Taken together, we generated a novel information source 239 
comprising 495 phosphorylation sites in 182 human proteins (Table S1) that 240 
combines 380 sites found in normal red cells and 274 sites described for infected red 241 
cells with 158 phospho-sites in common, as depicted in the Venn diagram (Fig. 1A). 242 
The distribution of phosphorylation sites by amino acid in infected cells and normal 243 
RBCs (Fig. 1B) is similar to a previous large scale phosphorylation study in humans 244 
reporting 6600 sites [30]. We find similar distributions of phospho-sites between 245 
infected cells and normal cells for serine (79.9% vs 76.3%) and threonine (18.2% vs 246 
9 
 
17.9%) and higher tyrosine phosphorylation for normal cells with 5.8% compared to 247 
1.8% in infected cells. 248 
We supplemented the phosphorylation information with knowledge from additional 249 
sources about these sites and found that 17 sites have been reported in the review 250 
by Pantaleo et al. [4] about phosphorylation changes in red cell membranes of 251 
normal and diseased red cells, and that 359 sites (72.5%) are stored in the Kinexus 252 
PhosphoNET database [31] including 267 sites with experimental evidence for 253 
detection in various cell types and 92 bioinformatically predicted sites. We also 254 
compared our compendium of phosphorylation sites with results from small scale 255 
protein phosphorylation studies [4,12] by two dimensional gel electrophoresis 256 
combined with mass spectrometry in normal RBCs and P. falciparum trophozoite-257 
infected RBCs. Wu et al. [12] reported 34 human protein phosphorylation sites of 258 
which 25 are present in our compendium, and Pantaleo et al. [4] identified 22 259 
phospho-sites during parasite growth including 3 reported here. Finally, we added 260 
gene ontology cellular localisation annotation to highlight phosphorylation sites in the 261 
red cell cytoskeleton. In total we find 94 RBC cytoskeleton phospho-sites specifically 262 
detected in infected cells, and 143 specific sites in the membrane of normal RBCs. 263 
3.2. Phosphorylation motif analysis 264 
Our compendium of 495 phosphorylation sites detected in normal and P. falciparum-265 
infected red blood cells enabled us to identify shared phosphorylation motifs and to 266 
predict associated protein kinase activity in red cells. Firstly, we compared 267 
phosphorylation motif classes between infected and normal red cells (Fig. 1C), with 268 
motif classes based on their chemical properties previously described in the schizont 269 
phosphoproteome [14]. Almost identical distributions of the acidic and proline-270 
directed classes are found between normal and infected RBCs, whereas a 3.25-fold 271 
upregulation of basic-directed motifs and a 3-fold downregulation in tyrosine-directed 272 
motifs are observed in iRBCs. Secondly, phosphorylation sites were mapped to 273 
motifs with the phosphorylation motif finding algorithm MotifX [18], and we identified 274 
7 phosphorylation motifs (Fig. 1D): 4 acidic-directed motifs (motif 1: [pS/pT]xx[E/D], 4: 275 
[pS/pT]x[E], 6: [pS/pT] [E/D] [E/D],[E/D], 7: [pS/pT]x[E/D][E/D]), 2 proline-directed 276 
motifs (motif 2: [pS/pT][P], 5: [R/K]xx[pS/pT][P] and 1 basic-directed motif (motif 3: 277 
[R/K]xx[pS/pT]. All these phosphorylation motifs were observed in proteins from 278 
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normal and infected red cells (Fig. 1D). Phosphorylation sites specifically detected in 279 
normal RBCs include all 7 motifs, while sites identified exclusively in infected RBCs 280 
include 5 motifs with the exceptions of motifs 6 and 7 that were not mapped on 281 
specific sites in iRBCs. Thirdly, the 7 motifs were associated with kinase target sites 282 
by PhosphoMotifFinder [20], where we consider primarily human protein kinases 283 
which have been detected in red blood cells by mass spectrometry (Table S2) 284 
[32,33]. This linked casein kinase II to 133 phosphorylation sites (motifs 1,4, 6 and 7) 285 
and protein kinase A/protein kinase C to 78 sites with motifs 3 and 5. Motif 2 286 
[pS/pT][P] is mapped to several protein kinases (ERK1,ERK2, CDPK5 and GSK3) 287 
with 67 sites, where all four kinases have escaped detection by mass spectrometry 288 
in RBCs so far [32,33]. 289 
3.3. Functional Implications of RBC phospho-proteomes 290 
The functional implications of the phospho-proteome to RBC physiology were 291 
assessed by GO enrichment analyses of the 123membrane associated RBC 292 
phospho-proteins compared to all human proteins using DAVID [21,22]. The 293 
enrichment results for cellular component, molecular function and biological process 294 
ontologies are depicted as a histogram plot with bars representing terms for infected 295 
and normal RBCs (Fig. 2A). The strongest signals are found for the spectrin-296 
associated cytoskeleton with 170-fold enrichment for infected RBCs and 115-fold 297 
enrichment in normal red cells, followed by spectrin-binding with 154-fold enrichment 298 
in infected RBCs and 114-fold enrichment in normal RBCs. This trend of stronger 299 
enrichment in iRBCs than in normal RBCs is observed for all cytoskeleton-related 300 
GO terms. All GO terms functionally associated with the cytoskeleton and surface 301 
membrane of infected RBCs were organized and visualised in a network (Fig. 2B) 302 
using the Cytoscape plugin Enrichment Map [23], where each term is represented by 303 
a node with edges showing degree of overlap between GO term sets.  The 304 
cytoskeleton subnetwork of infected RBC GO terms – depicted as cluster A in Fig. 305 
2B – is composed of 35 terms out of 43, with 8 terms specific for iRBCs and 27 306 
terms showing higher enrichment in iRBCs.     307 
Most terms relate to cytoskeleton organization and regulatory processes, e.g. for 308 
actin filament polymerization and protein complex assembly, and thereby highlighting 309 
associated proteins with roles in orchestrating red cell shape and deformability. The 310 
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filament proteins making up the ordered meshwork forming the cytoskeleton in red 311 
cells are observed phosphorylated in infected and normal red cells (Fig. 3A). 312 
Spectrins, actin, protein 4.1, adducin, dematin, tropomyosin and tropomodulin show 313 
multiple phosphorylation sites presumably regulating cytoskeleton organization. 314 
Several transmembrane glycoproteins with transbilayer domains (Band 3, 315 
glycophorin C) anchoring the cytoskeleton via their cytoplasmic domains are 316 
regulated by kinase activity via multiple phosphorylation sites. 317 
The phosphorylation status in our compendium for the main erythrocyte cytoskeleton 318 
proteins, transporters and various membrane associated proteins in normal and 319 
infected RBCs is listed in Fig. 3B, which shows that P. falciparum infection likely 320 
induces specific changes in RBC phosphorylation status. For the cytoskeleton 321 
protein 4.2, spectrin alpha chain, the glucose transporter 1 (GLUT-1), and for 322 
membrane associated proteins we observe strong upregulation of P. falciparum 323 
induced sites with the detection of more than 50% specific sites. 324 
3.4. Wet-bench validation of some phospho-sites and their cAMP dependence 325 
Given that infection of RBC by P. falciparum leads to a rise in intra-erythrocyte cAMP 326 
levels [34–37] combined with our identification of two potential PKA phosphorylation 327 
motifs we decided to ask how many of the phospho-sites detected in infected 328 
erythrocyte proteins are phosphorylated by a cAMP-dependent kinase. To this end, 329 
we compared the phosphorylation status of red blood cell adducin, dematin, Band 3 330 
and GLUT-1 in uninfected RBC stimulated or not by cAMP-stimulation to their 331 
phosphorylation status in iRBC (Fig. 4). With adducin we focussed on two phospho-332 
sites; namely, Ser59 and Ser726 and for dematin we examined Ser403, as for both 333 
proteins antibodies against these specific phospho-sites are commercially available 334 
(Fig. 4A). Phosphorylation of Ser59 in adducin can be observed in uninfected ghost 335 
lysates (lane 1), where the degree of phosphorylation increases following cAMP-336 
stimulation (lane 2) and is completely ablated by phosphatase treatment (lane 3). 337 
Thus, Ser59 is a bona fide cAMP-dependent kinase site. Ser59 is also observed in 338 
iRBC ghost lysates and the phospho-signal is ablated by phosphatase treatment 339 
(lane 5). However, comparing lanes 1 and 4 leads to the conclusion that - although 340 
Ser59 is a cAMP dependent site - the level of phosphorylation in iRBC is similar to 341 
non-infected erythrocytes i.e. infection doesn't appear to increase phosphorylation of 342 
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Ser59. By contrast, Ser726 of adducin is phosphorylated only in iRBC, and in non-343 
infected erythrocytes phosphorylation of Ser726 is not sensitive to cAMP stimulation 344 
(compare lanes 2 and 4). Phosphorylation of Ser726 in iRBC is ablated by 345 
phosphatase treatment, but this site does not appear to be a substrate for a cAMP-346 
dependent kinase. Ser726 occurs within a motif 3 context (Fig. 1D) that was 347 
ambiguously mapped to PKA or PKC and the data in Fig. 4A suggests that in 348 
infected RBC it is PKC rather than PKA that phosphorylates Ser726 of adducin.  349 
Ser403 in dematin can be observed weakly phosphorylated in erythrocyte ghost 350 
lysates (lane 1) and its phospho-status increases under the influence of cAMP (lane 351 
2) and is significantly diminished by phosphatase treatment (lane 3). In infected 352 
erythrocytes one can observe a strong band that is insensitive to phosphatase 353 
treatment (lanes 4 and 5) indicating a likely non-specific cross-reactivity of the 354 
pSer403 antibody to an unknown parasite protein present in the iRBC ghost 355 
preparation.  356 
The apparent lower molecular weights of 48 and 52 kDa dematin isoforms following 357 
phosphatase treatment of iRBCs sample (Fig. 4A; lane 5 lower panel) suggest that 358 
dematin phosphorylation is maintained at other phosphorylatable residues during P. 359 
falciparum infection.  360 
We next turned our attention to Band 3 and GLUT-1 to which there are no available 361 
phospho-specific serine or threonine antibodies, so we exploited the availability of 362 
commercial antibodies to sites phosphorylated in the context of an RxxS*/T* motif. 363 
We recall that the RxxS*/T* motif is present in cAMP-dependent PKA motif following 364 
our analysis of RBC proteins detected phosphorylated in vivo (Fig. 1D). First, the 365 
levels of both Band 3 and GLUT-1 were determined for RBC (lane 1), RBC 366 
stimulated by cAMP (lane 2) and for iRBC (lane 3). We note the drastic reduction in 367 
GLUT-1 levels observed in iRBC (lane 3) and that GLUT-1 appears highly 368 
glycosylated as judged by the smear-like signal (lanes 1 and 2). Both α-adducin and 369 
dematin levels were used as a loading control (input). Following immunoprecipitation 370 
with the sepharose-linked anti-RxxS*/T* antibody the amounts of Band 3 and GLUT-371 
1 in the precipitate were estimated by Western blot (top two panels; IP anti-372 
RxxS*/T*). Band 3 is readily detected phosphorylated at an RxxS*/T* site in iRBC 373 
(lane 3) and weakly detected in non-infected erythrocytes (lane 1). However, the 374 
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phosphorylation level is not increased following cAMP stimulation (lane 2) indicating 375 
that the strong signal observed following infection (lane 3) is likely to be due to 376 
erythrocyte PKC that like PKA can phosphorylate residues in the context of the 377 
RxxS*/T* motif.  378 
The low levels of GLUT-1 observed by Western Blot for iRBC (input, lane 3) and the 379 
observed smeared signal that has been reported to be the result of protein 380 
glycosylation [38] lead us to estimate the amount of GLUT-1 present in our ghost 381 
preparations by mass spectrometry analysis of digested protein samples using label 382 
free quantification LFQ [39] (Fig. 3C). Here, glycosylation does not interfere with the 383 
quantification measurement and similar GLUT-1 relative protein abundances were 384 
determined in infected and normal RBCs, which was expected due to the high levels 385 
of glucose consumption by iRBC [40]. After immunoprecipitation with anti-RxxS*/T*, 386 
however, the signal in iRBCs (lane 3) appears stronger than in non-infected cells, 387 
stimulated or not by cAMP (lane 1 and 2). As for Band 3, this suggests an increase 388 
in GLUT-1 phosphorylation for this motif upon infection.  389 
4. Discussion 390 
In this study we used a comparative analysis of phosphorylation sites between 391 
normal and P. falciparum-infected red blood cells and showed that the main host 392 
proteins determining cell shape, rigidity/ deformability or permeability are 393 
differentially phosphorylated/dephosphorylated upon infection. The compendium of 394 
human sites was compiled from published phospho-proteome studies generated by 395 
liquid chromatography tandem mass spectrometry focussed at the schizont life cycle 396 
stage during asexual development in RBCs. These sites were reported in 397 
supplementary tables as ‘by-products’ to P. falciparum phosphorylation sites without 398 
further functional interpretation and have gone largely unnoticed. 399 
Our phosphorylation analysis is quite stringent, as it required that a given phospho-400 
site be detected in at least 2 independent studies done in separate laboratories. This 401 
identified 495 sites in 182 human RBC proteins of which 379 sites in 153 proteins 402 
can be detected in normal RBC, and 274 sites (91 proteins) detected in iRBC of 403 
which 158 in 57 proteins are in common. This indicates that 116 sites belonging to 404 
50 proteins appear to be specifically phosphorylated upon P. falciparum infection, 405 
and that 221 sites belonging to 113 proteins are likely be subjected to phosphatase 406 
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activities in iRBCs. Strikingly, in iRBCs tyrosine phosphorylation appears less 407 
frequent (5.8% down to 1.8%) suggesting that infection has induced tyrosine 408 
phosphatase activity. The parasite lacks any gene encoding classical tyrosine 409 
kinases [41] and consequently, all tyrosine phosphorylation events in erythrocyte and 410 
parasite proteins likely derive from erythrocyte tyrosine kinase activity. We consider 411 
the alternative explanation of incorrect phosphorylation localisation in normal RBCs 412 
less likely than increased phosphatase activity in iRBCs given that 62.5% of the sites 413 
have been confirmed experimentally, or predicted [31]. Amongst the 22 pY sites in 414 
normal RBCs we find a site in a protein phosphatase (PTPRD_HUMAN Y274) 415 
potentially involved in switching on phosphatase activity in infected RBCs. Other 416 
candidate tyrosine phosphatases in red cells are ACP1 and PTPRC (CD45) that 417 
have been detected in red cells by mass spectrometry [32,33] (Table S2).  418 
Previous small scale phosphorylation studies in iRBCs of the trophozoite life cycle 419 
stage by Wu et al. [12] and Pantaleo et al. [4] analysed respectively 34 and 18 spots 420 
(Table S3) isolated from two dimensional protein gels. The majority of the sites 421 
(73.5%) detected by Wu et al. are present in our compendium that is covering the 422 
schizont asexual life cycle stage, but not the trophozoite stage, while most sites 423 
detected by Pantaleo et al. (86%) are absent in our compendium. These studies 424 
highlighted the role of protein phosphorylation in the interactions between the 425 
parasite and its human erythrocyte host and reported phosphorylation sites in key 426 
cytoskeletal proteins, e.g. spectrin beta, ankyrin 1, Band 3, alpha and beta adducin, 427 
Band 4.1, and dematin. All these proteins are found phosphorylated in our 428 
compendium, although some sites have escaped detection. Dematin pS403 is an 429 
example that has been detected by peptide NELKKKApSLF that allows for three 430 
miscleaved tryptic sites in the identification searches. In our compendium most 431 
studies utilised standard identification settings including 2 miscleavages and thereby 432 
likely excluded the identification of this peptide. 433 
The role of protein phosphorylation in alterations of red cell membrane and 434 
cytoskeleton is evident from the GO enrichment analysis of the 123 membrane-435 
associated RBC phosphoproteins (Fig. 2). This analysis shows that spectrin-436 
associated cytoskeleton is 170-fold enriched in iRBC up from 114-fold in normal 437 
RBC, which supports the findings of trophozoite-infected red blood cells [4,12]. 438 
Generally, it is consistent with infection particularly inducing phosphorylation of 439 
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spectrin-associated functions like actin filament polymerization and protein complex 440 
assembly highlighting parasite-induced orchestration of red cell shape and 441 
deformability. For example, following P. falciparum infection more than 50% of the 442 
specifically induced sites were in protein 4.2, spectrin alpha chain and the glucose 443 
transporter GLUT-1 (Fig. 3).  444 
We identified 7 short linear consensus sequences around phosphorylated residues 445 
determining the phosphorylation motif for protein kinase activities for 56% of the 446 
phosphorylation site compendium. The phosphorylation motifs are observed in 447 
normal and infected RBCs suggesting that human kinase activity is primarily 448 
responsible for phosphorylation events involving these sites in infected RBCs. Global 449 
proteome studies of red cells [32,33] reveal a limited repertoire of 16 human 450 
serine/threonine protein kinases (Table S2) potentially recognising these 7 451 
phosphorylation consensus site motifs. The limited number of protein kinases 452 
detected by mass spectrometry in RBCs facilitates linking protein kinase activities 453 
with phosphorylation motifs by eliminating protein kinases that are absent in RBCs 454 
from ambiguous bioinformatics predictions. This revealed prominent roles for casein 455 
kinase II (CK2) activity in red cells with 133 predicted sites, and agrees well with the 456 
reported involvement of CK2 in phosphorylating cytoskeletal proteins (e.g. spectrin, 457 
adducin, ankyrin, and protein 4.1) [42,43], in phosphorylation of the blood group 458 
antigens Kell and Kx [44], in regulation of spectrin binding by phosphorylated ankyrin 459 
[45] and in regulating cytoadherence of P. falciparum-infected red blood cells [46].  460 
Although all CK2 sites were observed in normal and infected RBCs, the 34 CK2 sites 461 
mapping to motifs 6 and 7 (Fig. 1D) are absent in the sites exclusively observed in 462 
infected RBCs. This suggests that parasite infection induces phosphatase activities 463 
that dephosphorylate CK2-positive sites to modulate red cell morphology. Protein 4.1, 464 
which is a major structural element of the red cell cytoskeleton and regulates 465 
mechanical stability, is dephosphorylated upon infection at pS104 and pS95, and 466 
ankyrin – which forms the bridge between the integral membrane protein Band 3 and 467 
spectrin – is dephosphorylated at pS817.  468 
The motif analysis highlighted prominent roles for PKA/PKC involving 78 469 
phosphorylation sites. For this reason, we compared the phosphorylation status of 470 
specific sites in adducin, dematin, Band 3 and GLUT-1 in uninfected RBC stimulated 471 
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or not by cAMP to their phosphorylation status in iRBC. With adducin we focussed 472 
on two phospho-sites; namely, Ser59 and Ser726 and for dematin we examined 473 
Ser403, as both proteins can be phosphorylated at these sites by cAMP-dependent 474 
PKA [47–50], and phosphosite-specific antibodies are commercially available. When 475 
we examined Ser59 of adducing in normal RBC we observed an increase in its 476 
phosphorylation status following cAMP-stimulation. We point out that cAMP-477 
stimulation was performed using intact RBCs, right before ghost preparation. 478 
However with this caveat, P. falciparum infection that leads to increased cAMP levels 479 
and greater PKA activity [34–37] does not lead to a detectable increase in Ser59 480 
phosphorylation in iRBC. By contrast, Ser726 is detected as a doublet by the 481 
phospho-specific antibody only in iRBC, but its phosphorylation in uninfected RBC 482 
isn't induced following cAMP-stimulation implying that in iRBC Ser726 483 
phosphorylation is not by cAMP-dependent PKA, but perhaps by another host or 484 
exported parasite AGC-like kinase. There are two isoforms of dematin in normal 485 
RBC [32,33] and Ser403 phosphorylation is induced up cAMP-stimulation [47–49], 486 
but neither isoform is observed phosphorylated in iRBC, suggesting that infection 487 
has led to dephosphorylation of S403 in dematin. Surprisingly, the commercial 488 
phospho-Ser403 antibody strongly detected a signal band in iRBC that likely 489 
represents a cross-reactive parasite protein present in the ghost preparation.  490 
As there are no specific antibodies to phosphorylated serines and threonines in Band 491 
3 and GLUT-1 we exploited a commercial sepharose-linked antibody that reacts with 492 
residues phosphorylated in the context of RxxS*/T* that resembles closely the 493 
enriched PKA motifs (3 & 5 in Fig. 1D). Following immunoprecipitation the 494 
precipitates were probed with specific antibodies to Band 3 and GLUT-1. P. 495 
falciparum-infection of RBC induces phosphorylation of Band 3 at one or more 496 
RxxS*/T* sites and careful inspection of human Band 3 reveals the presence of 3 497 
sites (RyqS*(S349); KpdS*(S356) and KasT*(T746)) all of which have been detected 498 
phosphorylated in iRBC [14,16]. However, cAMP-stimulation of normal RBC did not 499 
induce phosphorylation at any RxxS*/T* site implying that in iRBC infection-induced 500 
phosphorylation at S349, S356, or T746 is by cAMP-independent kinase.  501 
The situation with GLUT-1 is very intriguing, as LC–MS/MS measurements showed 502 
that GLUT-1 protein levels are equal between uninfected and infected red blood cells, 503 
while phosphorylated GLUT-1 appears enriched in anti-RxxS*/T* immunoprecipitates 504 
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from iRBC (Fig. 4B). This result is consistent with the five GLUT-1 phospho-peptides 505 
detected specifically in iRBC (Fig. 3). Direct detection with anti-motif 4 (RxxS*/T*) of 506 
phosphorylated GLUT-1 by probing immunoblots of anti-GLUT-1 immunoprecipitates 507 
is difficult due to the glycosylation smear and reduced GLUT-1 signal in iRBCs.We 508 
propose that upregulation of GLUT-1 phosphorylation may be essential for the 509 
heightened glucose uptake of iRBC that fuels the parasite's energy metabolism and 510 
leads to high lactate output. Further experiments are required to investigate whether 511 
phosphorylation of GLUT-1 does indeed underpin increased glucose uptake by iRBC 512 
as inhibiting GLUT-1 kinase(s) could impact negatively on parasite growth. 513 
5. Conclusion 514 
In this study we generated a comprehensive compendium of protein phosphorylation 515 
sites in erythrocyte membrane proteins from normal and P. falciparum-infected 516 
RBCs. We demonstrated that the compendium is a new information source for 517 
exploration of phosphorylation sites involved in regulating red cell morphology and 518 
metabolite transport. 519 
Funding 520 
This work was supported by the Royal Society (UK) with the International Exchanges 521 
Scheme — 2013/R3 grant to E.L. and G.B. GB and SE were supported by the labex 522 
GR-Ex, reference ANR-11- LABX-0051, funded by the program “Investissements 523 
dxavenir” of the French National Research Agency, reference ANR-11-IDEX-0005-524 
02. GL acknowledges support from ParaFrap (ANR-11-LABX-0024), INSERM and 525 
the CNRS. 526 
  527 
18 
 
References 528 
[1] F. Roux-Dalvai, A. Gonzalez de Peredo, C. Simó, L. Guerrier, D. Bouyssié, A. 529 
Zanella, A. Citterio, O. Burlet-Schiltz, E. Boschetti, P.G. Righetti, B.Monsarrat,  530 
Extensive analysis of the cytoplasmic proteome of human erythrocytes using the 531 
peptide ligand library technology and advanced mass spectrometry, Mol. Cell. 532 
Proteomics 7 (2008) 2254–2269. 533 
[2] S.R. Goodman, O. Daescu, D.G. Kakhniashvili, M. Zivanic, The proteomics and 534 
interactomics of human erythrocytes, Exp. Biol. Med. (Maywood) 238 (2013) 509–535 
518. 536 
[3] A. Pantaleo, L. De Franceschi, E. Ferru, R. Vono, F. Turrini, Current knowledge 537 
about the functional roles of phosphorylative changes of membrane proteins in 538 
normal and diseased red cells, J. Proteomics 73 (2010) 445–455. 539 
[4] A. Pantaleo, E. Ferru, F. Carta, F. Mannu, G. Giribaldi, R. Vono, A.J. Lepedda, P. 540 
Pippia, F. Turrini, Analysis of changes in tyrosine and serine phosphorylation of red 541 
cell membrane proteins induced by P. falciparum growth, Proteomics 10 (2010) 542 
3469–3479. 543 
[5] S. Manno, Y. Takakuwa, K. Nagao, N. Mohandas, Modulation of erythrocyte 544 
membrane mechanical function by β-spectrin phosphorylation and  545 
dephosphorylation, J. Biol. Chem. 270 (1995) 5659–5665. 546 
[6] S. Perrotta, E.M. del Giudice, A. Iolascon, M. De Vivo, D. Di Pinto, S. Cutillo, B. 547 
Nobili,Reversible erythrocyte skeleton destabilization is modulated by beta-spectrin 548 
phosphorylation in childhood leukemia, Leukemia 15 (2001) 440–444. 549 
[7] S. Manno, Y. Takakuwa, N. Mohandas, Modulation of erythrocyte membrane 550 
mechanical function by protein 4.1 phosphorylation, J. Biol. Chem. 280 (2005) 7581–551 
7587. 552 
[8] E. Ferru, K. Giger, A. Pantaleo, E. Campanella, J. Grey, K. Ritchie, R. Vono, F. 553 
Turrini, P.S. Low, Regulation of membrane-cytoskeletal interactions by tyrosine 554 
phosphorylation of erythrocyte band 3, Blood 117 (2011) 5998–6006. 555 
19 
 
[9] S. Baumeister, P. Gangopadhyay, U. Repnik, K. Lingelbach, Novel insights into 556 
red blood cell physiology using parasites as tools, Eur. J. Cell Biol. 94 (2015) 332–557 
339. 558 
[10] K. Kirk, A.M. Lehane, Membrane transport in the malaria parasite and its host 559 
erythrocyte, Biochem. J. 457 (2014) 1–18. 560 
[11] S. Sanyal, S. Egee, G. Bouyer, S. Perrot, I. Safeukui, E. Bischoff, P. Buffet, K.W. 561 
Deitsch, O. Mercereau-Puijalon, P.H. David, T.J. Templeton, C. Lavazec, 562 
Plasmodium falciparum STEVOR proteins impact erythrocyte mechanical properties, 563 
Blood 119 (2012) e1–e8. 564 
[12] Y. Wu, M.M. Nelson, A. Quaile, D. Xia, J.M.Wastling, A. Craig, Identification of 565 
phosphorylated proteins in erythrocytes infected by the human malaria parasite 566 
Plasmodium falciparum, Malar. J. 8 (2009) 105. 567 
[13] M.O. Collins, J.C. Wright, M. Jones, J.C. Rayner, J.S. Choudhary, Confident and 568 
sensitive phosphoproteomics using combinations of collision induced dissociation 569 
and electron transfer dissociation, J. Proteomics 103 (2014) 1–14. 570 
[14] E. Lasonder, J.L. Green, G. Camarda, H. Talabani, A.A. Holder, G. Langsley, P. 571 
Alano, The Plasmodium falciparum schizont phosphoproteome reveals extensive 572 
phosphatidylinositol and cAMP-protein kinase A signaling, J. Proteome Res. 11 573 
(2012) 5323–5337. 574 
[15] L. Solyakov, J. Halbert, M.M. Alam, J.P. Semblat, D. Dorin-Semblat, L. 575 
Reininger, A.R. Bottrill, S. Mistry, A. Abdi, C. Fennell, Z. Holland, C. Demarta, Y. 576 
Bouza, A. Sicard, M.P. Nivez, S. Eschenlauer, T. Lama, D.C. Thomas, P. Sharma, S. 577 
Agarwal, S. Kern, G. Pradel, M. Graciotti, A.B. Tobin, C. Doerig, Global kinomic and 578 
phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum, 579 
Nat. Commun. 2 (2011) 565. 580 
[16] M. Treeck, J.L. Sanders, J.E. Elias, J.C. Boothroyd, The phosphoproteomes of 581 
Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within 582 
and beyond the parasites' boundaries, Cell Host Microbe 10 (2011) 410–419. 583 
[17] E.J. Soderblom, J.W. Thompson, E.A. Schwartz, E. Chiou, L.G. 584 
Dubois,M.A.Moseley, R. Zennadi, Proteomic analysis of ERK1/2-mediated human 585 
20 
 
sickle red blood cell membrane protein phosphorylation, Clin. Proteomics 10 (2013) 586 
1. 587 
[18] D. Schwartz, S.P. Gygi, An iterative statistical approach to the identification of 588 
protein phosphorylation motifs from large-scale data sets, Nat. Biotechnol. 23 (2005) 589 
1391–1398. 590 
[19] G.E. Crooks, G. Hon, J.M. Chandonia, S.E. Brenner,WebLogo: a sequence logo 591 
generator,Genome Res. 14 (2004) 1188–1190. 592 
[20] R. Amanchy, B. Periaswamy, S.Mathivanan, R. Reddy, S.G. Tattikota, A. 593 
Pandey, A curated compendium of phosphorylation motifs, Nat. Biotechnol. 25 (2007) 594 
285–286. 595 
[21] W. Huang da, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis 596 
of large gene lists using DAVID bioinformatics resources, Nat. Protoc. 4 (2009) 44–597 
57. 598 
[22] W. Huang da, B.T. Sherman, Q. Tan, J.R. Collins,W.G. Alvord, J. Roayaei, R. 599 
Stephens, M.W. Baseler, H.C. Lane, R.A. Lempicki, The DAVID Gene Functional 600 
ClassificationTool: a novel biological module-centric algorithm to functionally analyze 601 
large gene lists, Genome Biol. 8 (2007) R183. 602 
[23] D. Merico, R. Isserlin, G.D. Bader, Visualizing gene-set enrichment results using 603 
the Cytoscape plug-in enrichment map, Methods Mol. Biol. 781 (2011) 257–277. 604 
[24] A. Radfar, D. Mendez, C. Moneriz, M. Linares, P. Marin-Garcia, A. Puyet, A. 605 
Diez, J.M.Bautista, Synchronous culture of Plasmodium falciparum at high 606 
parasitemia levels, Nat. Protoc. 4 (2009) 1899–1915. 607 
[25] J.R. Wisniewski, A. Zougman, N. Nagaraj, M. Mann, Universal sample 608 
preparation method for proteome analysis, Nat. Methods 6 (2009) 359–362. 609 
[26] J. Rappsilber, Y. Ishihama, M. Mann, Stop and go extraction tips for matrix-610 
assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample 611 
pretreatment in proteomics, Anal. Chem. 75 (2003) 663–670. 612 
[27] L. Zhou, J. Lyons-Rimmer, S. Ammoun, J. Muller, E. Lasonder, V. Sharma, E. 613 
Ercolano, D. Hilton, I. Taiwo, M. Barczyk, C.O. Hanemann, The scaffold protein 614 
21 
 
KSR1, a novel therapeutic target for the treatment of merlin-deficient tumors, 615 
Oncogene (2015). 616 
[28] J. Cox, M. Mann, MaxQuant enables high peptide identification rates, 617 
individualized p.p.b.-range mass accuracies and proteome-wide protein 618 
quantification, Nat. Biotechnol. 26 (2008) 1367–1372. 619 
[29] E. Lasonder, M. Treeck, M. Alam, A.B. Tobin, Insights into the Plasmodium 620 
falciparum schizont phospho-proteome, Microbes Infect. 14 (2012) 811–819. 621 
[30] J.V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, M. Mann, 622 
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks, 623 
Cell 127 (2006) 635–648. 624 
[31] http://www.phosphonet.ca/, PhosphoNET. 625 
[32] T. Hegedus, P.M. Chaubey, G. Varady, E. Szabo, H. Saranko, L. Hofstetter, B. 626 
Roschitzki, B. Stieger, B. Sarkadi, Inconsistencies in the red blood cell membrane 627 
proteome analysis: generation of a database for research and diagnostic 628 
applications, Database (Oxford) 2015 (2015), bav056. 629 
[33] http://rbcc.hegelab.org, Red Blood Cell Collection. 630 
[34] A. Dawn, S. Singh, K.R.More, F.A. Siddiqui, N. Pachikara, G. Ramdani, G. 631 
Langsley, C.E. Chitnis, The central role of cAMP in regulating Plasmodium 632 
falciparum merozoite invasion of human erythrocytes, PLoS Pathog. 10 (2014), 633 
e1004520. 634 
[35] A. Merckx, M.P. Nivez, G. Bouyer, P. Alano, G. Langsley, K. Deitsch, S. Thomas, 635 
C. Doerig, S. Egee, Plasmodium falciparum regulatory subunit of cAMP-dependent 636 
PKA and anion channel conductance, PLoS Pathog. 4 (2008), e19. 637 
[36] G. Ramdani, B. Naissant, E. Thompson, F. Breil, A. Lorthiois, F. Dupuy, R. 638 
Cummings, Y. Duffier, Y. Corbett, O. Mercereau-Puijalon, K. Vernick, D. Taramelli, 639 
D.A. Baker, G. Langsley, C. Lavazec, cAMP-signalling regulates gametocyte-640 
infected erythrocyte deformability required for malaria parasite transmission, PLoS 641 
Pathog. 11 (2015), e1004815. 642 
22 
 
[37] C. Syin, D. Parzy, F. Traincard, I. Boccaccio, M.B. Joshi, D.T. Lin, X.M. Yang, K. 643 
Assemat, C. Doerig, G. Langsley, The H89 cAMP-dependent protein kinase inhibitor 644 
blocks Plasmodium falciparum development in infected erythrocytes, Eur. J. 645 
Biochem. 268 (2001) 4842–4849. 646 
[38] J.F. Flatt, H. Guizouarn, N.M. Burton, F. Borgese, R.J. Tomlinson, R.J. Forsyth, 647 
S.A.Baldwin, B.E. Levinson, P. Quittet, P. Aguilar-Martinez, J. Delaunay, G.W. 648 
Stewart, L.J. Bruce, Stomatin-deficient cryohydrocytosis results from mutations in 649 
SLC2A1: a novel formof GLUT1 deficiency syndrome, Blood 118 (2011) 5267–5277. 650 
[39] J. Cox, M.Y. Hein, C.A. Luber, I. Paron, N. Nagaraj, M. Mann, Accurate 651 
proteome-wide label-free quantification by delayed normalization and maximal 652 
peptide ratio extraction,termed MaxLFQ, Mol. Cell. Proteomics 13 (2014) 2513–2526. 653 
[40] M. Urscher, R. Alisch, M. Deponte, The glyoxalase system of malaria parasites 654 
— implications for cell biology and general glyoxalase research, Semin. Cell Dev. 655 
Biol. 22 (2011) 262–270. 656 
[41] D. Miranda-Saavedra, T. Gabaldon, G.J. Barton, G. Langsley, C. Doerig, The 657 
kinomes of apicomplexan parasites, Microbes Infect. 14 (2012) 796–810. 658 
[42] G. Clari, V.Moret, Phosphorylation ofmembrane proteins by cytosolic casein 659 
kinases in human erythrocytes. Effect of monovalent ions, 2,3-bisphosphoglycerate 660 
and spermine, Mol. Cell. Biochem. 68 (1985) 181–187. 661 
[43] T.Wei, M. Tao, Human erythrocyte casein kinase II: characterization and 662 
phosphorylation of membrane cytoskeletal proteins, Arch. Biochem. Biophys. 307 663 
(1993) 206–216. 664 
[44] F. Carbonnet, C. Hattab, J.P. Cartron, O. Bertrand, Kell and Kx, two disulfide-665 
linked proteins of the human erythrocytemembrane are phosphorylated in vivo, 666 
Biochem.Biophys. Res. Commun. 247 (1998) 569–575. 667 
[45] S. Ghosh, F.C. Dorsey, J.V. Cox, CK2 constitutively associateswith and 668 
phosphorylates chicken erythroid ankyrin and regulates its ability to bind to spectrin, 669 
J. Cell Sci. 115 (2002) 4107–4115. 670 
23 
 
[46] R. Hora, D.J. Bridges, A. Craig, A. Sharma, Erythrocytic casein kinase II 671 
regulates cytoadherence of Plasmodium falciparum-infected red blood cells, J. Biol. 672 
Chem. 284 (2009) 6260–6269. 673 
[47] L. Chen, J.W. Brown, Y.F. Mok, D.M. Hatters, C.J.McKnight, The 674 
allostericmechanism induced by protein kinase A (PKA) phosphorylation of dematin 675 
(band 4.9), J. Biol.Chem. 288 (2013) 8313–8320. 676 
[48] L. Chen, J.W. Brown, Y.F. Mok, D.M. Hatters, C.J.McKnight, The 677 
allostericmechanism induced by protein kinase A (PKA) phosphorylation of dematin 678 
(band 4.9), J. Biol.Chem. 290 (2015) 17808. 679 
[49] I. Koshino, N. Mohandas, Y. Takakuwa, Identification of a novel role for dematin 680 
in regulating red cell membrane function by modulating spectrin–actin interaction, 681 
J.Biol. Chem. 287 (2012) 35244–35250. 682 
[50] Y. Matsuoka, C.A. Hughes, V. Bennett, Adducin regulation. Definition of the 683 
calmodulin-binding domain and sites of phosphorylation by protein kinases A and C, 684 
J. Biol. Chem. 271 (1996) 25157–25166. 685 
[51] E.S. Zuccala, T.J. Satchwell, F. Angrisano, Y.H. Tan, M.C. Wilson, K.J. Heesom, 686 
J. Baum, Quantitative phospho-proteomics reveals the Plasmodium merozoite 687 
triggers pre-invasion host kinase modification of the red cell cytoskeleton, Sci. Rep. 6 688 
(2016) 19766. 689 
[52] D. Walliker, I.A. Quakyi, T.E. Wellems, T.F. McCutchan, A. Szarfman, W.T. 690 
London, L.M. Corcoran, T.R. Burkot, R. Carter, Genetic analysis of the human 691 
malaria parasite Plasmodium falciparum, Science 236 (1987) 1661–1666. 692 
[53] C. Lambros, J.P. Vanderberg, Synchronization of Plasmodium falciparum 693 
erythrocytic stages in culture, J. Parasitol. 65 (1979) 418–420. 694 
  695 
24 
 
Figure Legends 696 
Fig. 1. Compendium of protein phosphorylation sites in human red blood cells 697 
Compendium of protein phosphorylation sites in human red blood cells. A. Venn 698 
diagram depicting phospho-peptide counts in normal and P. falciparum-infected 699 
RBCs with data collected by Soderblom et al. [17] (normal RBCs) and by several 700 
independent studies of the schizont life cycle stage [13–16]. B. Distribution of amino 701 
acid phosphorylation for serine, threonine and tyrosine in phospho-proteomes. C. Pie 702 
chart showing the distribution of phosphorylation motif classes in RBC proteins for 703 
normal and infected red cells. The phosphorylated residue is located at the central 704 
position within a sequence window of 13 amino acids. Classes were defined by the 705 
chemical properties of the sequence window peptide as acidic, basic, proline-706 
directed, tyrosine-directed or other by a decision tree method described earlier [14]. 707 
D. Table of phosphorylation motifs in normal and infected RBCs identified by Motif-X 708 
[18] analysis with phosphorylation motifs depicted as sequence logos. Putative 709 
protein kinases associated with these motifs were predicted by PhosphoMotifFinder 710 
[20]. 711 
Fig. 2. Functional annotation of red blood cell phospho-proteomes 712 
Functional annotation of red blood cell phospho-proteomes. A. GO enrichment of 713 
membrane-associated phosphoproteins in normal and infected RBCs for the 714 
ontologies molecular function (red bars), cellular component (green bars), and 715 
biological processes (blue bars). Fold enrichment in the phospho-proteome relative 716 
to the human proteomeis displayed at the xaxis. B. Network visualisation of the 717 
overlap between enriched GO terms in infected RBCs by Cytoscape plugin 718 
Enrichment Map. Nodes represent GO terms and edges display overlap between 719 
terms with line thickness corresponding to degree of overlap. Node numbers refer to 720 
GO terms listed in the left column in A. 721 
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Fig. 3. Phosphorylation of RBCmembrane and cytoskeleton proteins 723 
A. Schematic representation of a cross section from the red cell membrane shows 724 
protein phosphorylation of the key players spectrin, actin, tropomyosin and Band 4.1, 725 
which are forming a meshwork laminating the inner surface of the membrane. 726 
Linkage to the lipid bilayer membrane via ankyrin occurs with the transmembrane 727 
protein Band 3 and glycophorin C, the surface glycoprotein CD47, Rh and Rh-728 
associated glycoprotein (RhAG) establishing the bridges with the cytoskeleton 729 
meshwork. Proteins are provided with numbers representing counts of 730 
phosphorylation sites specifically detected in infected RBCs and counts of all sites. B. 731 
Table highlighting the phosphorylation status of the main erythrocyte cytoskeleton 732 
proteins, transporters and various membrane-associated proteins in normal and 733 
infected RBCs. *Proteins with more than 50% of infected specific sites. The majority 734 
of proteins in this figure (eg glycophorin A&C, ankyrin, spectrins, adducins, band 3, 735 
dematin, protein 4.1, GLUT1, CA1&2, actin, nucleoside transporter 1) have recently 736 
been reported phosphorylated following merozoite binding to the RBC surface 737 
(Zuccala ES et al, Sci. Rep. 6:19766 [51]). 738 
Fig. 4. Wet-bench validation of phospho-sites and their cAMP-dependence  739 
A. Immunoblots showing phospho-Ser59, phospho-Ser726 and α-adducin (81 kDa), 740 
left panel; phospho-Ser403 and α and β dematin (48 and 52 kDa), right panel; using 741 
ghost lysates obtained from uninfected RBCs (lanes 1–3) and N95%-enriched 742 
schizont stage of P. falciparum (NF54)-infected RBCs (lanes 4, 5); uninfected RBCs 743 
incubated 30 min at 37 °C in the presence of 50 μM dibutyryl-cAMP (lane 2); 744 
dephosphorylated ghost lysates prepared by incubation with λ-protein phosphatase 745 
(lanes 3, 5). 1 × 107 uninfected RBCs and P. falciparum (NF54)-infected RBCs 746 
representing 5 μg and 30 μg total proteins, respectively. B. Immunoprecipitation/ 747 
immunoblot analysis of ghost lysates from uninfected RBCs and N95%-enriched 748 
schizont stage of P. falciparum (NF54)-infected RBCs (1 × 108). Immunoblots of total 749 
ghost lysates, where lane 1 = uninfected RBC; lane 2 = RBC stimulated with cAMP; 750 
lane 3 = iRBC, showing levels of Band 3 (95 kDa) and GLUT-1 (54 kDa), with α-751 
adducin and dematin levels taken as loading controls (input). Top two panels show 752 
amounts of Band 3 and GLUT-1 immunoprecipitated by the anti-RxxS*/T* antibody 753 
(IP anti-RxxS*/T*). Note the drastically reduced Western blot signals of GLUT1 754 
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detected in total ghost lysates from iRBC (compare lanes 1, 2 with 3). The low-755 
amount of GLUT-1 in the anti-RxxS*/T* precipitate contrasts with phospho-Band 3 756 
that is readily detected (lane 3, top panel). C. Measurement of GLUT-1 protein 757 
abundance in isolated ghosts from infected and uninfected RBCs analysing 500 ng 758 
tryptic digests by liquid chromatography tandem mass spectrometry using label free 759 
quantification in triplicate runs. Similar GLUT-1 protein levels are observed in iRBC 760 
and RBC. 761 
 762 
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Figure  1763 
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Figure  2765 
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Figure  3769 
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Figure  4775 
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